Jet Airways shares slump after reports of Etihad's non-binding offer

Kannur, Jan 23: A member of Rashtriya Swayamsevak Sangh has been arrested for attempting to create unrest in Kerala by hurling crude bombs at RSS office and police picket. The miscreants had reportedly planned to pass the blame on others.

The bomb attack took place of January 16 in Kerala’s Kannur. The accused Prabesh, an RSS hardliner, was arrested from Coimbatore, Tamil Nadu.

According to the Kerala police Prabesh hurled steel bombs towards the police picket in front of Kathirur Manoj Smrithi Kendram, an RSS office.

"He threw bombs during the wee hours of January 16 morning. Following the arrest he has confessed that his aim was RSS office. Kannur, being politically sensitive region, any attack on political party offices will be regarded as an act by the opponent," Kathirur SI Nijeesh said.

"We had a police picket in the region for a few months now. We are assuming he wanted to create unrest in the area by removing the police from the spot. We could contain the situation because of the CCTV visuals. He was identified immediately after the incident. Following the attack he went to Coimbatore and was hiding there. Our team nabbed him from Coimbatore," he said.

The police have also said that the accused Prabesh had many criminal cases pending against him including those under Explosive Substances Act, 1883. He was nabbed by a team lead by Kathirur SI Nijeesh, CPO Rohith and Vijeesh.

The RSS office in the region is named after Kathirur Manoj a senior karyakarta (worker) who was allegedly killed by the CPI(M) activists in 2014. Kathirur Manoj was the prime accused in the attempt to murder of senior CPI(M) leader P Jayarajan in 1999.

Udupi, May 23: Five more persons tested positive for coronavirus in the coastal district of Udupi today. 

They include three men aged 37, 55, 31 and two women aged 48 and 34. 

Among them four are returnees from Mumbai and one is foreign returnee.

With this the total number of covid-19 cases in the district rose to 55.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.